Market Closed -
TEL AVIV STOCK EXCHANGE
07:24:08 2024-04-25 am EDT
|
5-day change
|
1st Jan Change
|
3,562
ILa
|
+1.51%
|
|
-1.03%
|
-6.44%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,219
|
10,159
|
9,418
|
9,032
|
-
|
-
|
Enterprise Value (EV)
1 |
6,219
|
10,159
|
9,418
|
9,032
|
9,032
|
9,032
|
P/E ratio
|
5.34
x
|
5.27
x
|
7.64
x
|
6.66
x
|
5.95
x
|
5.08
x
|
Yield
|
-
|
6.14%
|
3.57%
|
6.74%
|
8.14%
|
-
|
Capitalization / Revenue
|
371,544
x
|
-
|
-
|
-
|
-
|
-
|
EV / Revenue
|
371,544
x
|
-
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
1.05
x
|
0.93
x
|
0.76
x
|
0.72
x
|
-
|
Nbr of stocks (in thousands)
|
254,656
|
252,531
|
251,137
|
253,563
|
-
|
-
|
Reference price
2 |
24.42
|
40.23
|
37.50
|
35.62
|
35.62
|
35.62
|
Announcement Date
|
4/22/21
|
3/29/22
|
4/24/23
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2024
|
2025
|
2026
|
---|
Net sales
|
16,737
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
2,697
|
1,854
|
1,958
|
2,112
|
-
|
Net income
1 |
-
|
1,965
|
1,350
|
1,404
|
1,514
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
4.570
|
7.640
|
4.910
|
5.349
|
5.983
|
7.015
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
2.470
|
1.340
|
2.400
|
2.900
|
-
|
Announcement Date
|
4/22/21
|
3/29/22
|
4/24/23
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q1
|
2023 Q2
|
2023 Q3
|
---|
Net sales
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
Net income
|
-57.05
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
EPS
1 |
-0.2300
|
0.2300
|
0.4400
|
Dividend per Share
|
-
|
-
|
-
|
Announcement Date
|
5/31/23
|
8/24/23
|
11/29/23
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
26.3%
|
12.7%
|
11.8%
|
12%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
38.40
|
40.20
|
46.80
|
49.60
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/22/21
|
3/29/22
|
4/24/23
|
-
|
-
|
Last Close Price
35.62
ILS Average target price
48.5
ILS Spread / Average Target +36.16% Consensus |
1st Jan change
|
Capi.
|
---|
| -6.44% | 2.37B | | +15.94% | 79.51B | | +8.42% | 50.22B | | +2.47% | 48.11B | | +10.21% | 42.2B | | +7.93% | 39.71B | | +20.02% | 37.78B | | +2.62% | 30.07B | | -7.27% | 27.56B | | -16.43% | 24.71B |
Other Life & Health Insurance
|